Longshen Rongfa announced that the company recently received the “Proprietary Chinese Medicine Registration Certificate” for Yuanhu Pain Relief Pills approved and issued by the Macau Drug Administration, indicating that the company is qualified to sell this drug in Macau, which will help expand overseas market business and enhance brand and market competitiveness. The drug is the company's main product and a nationally exclusive product, and is not expected to have a significant impact on recent business performance.

Zhitongcaijing · 1d ago
Longshen Rongfa announced that the company recently received the “Proprietary Chinese Medicine Registration Certificate” for Yuanhu Pain Relief Pills approved and issued by the Macau Drug Administration, indicating that the company is qualified to sell this drug in Macau, which will help expand overseas market business and enhance brand and market competitiveness. The drug is the company's main product and a nationally exclusive product, and is not expected to have a significant impact on recent business performance.